193 related articles for article (PubMed ID: 18425361)
1. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
[TBL] [Abstract][Full Text] [Related]
2. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z
Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
[TBL] [Abstract][Full Text] [Related]
5. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
7. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.
Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H
Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
12. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
13. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
[TBL] [Abstract][Full Text] [Related]
16. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
[TBL] [Abstract][Full Text] [Related]
17. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
19. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
20. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma.
Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R
Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
